Of mice and men...with prostate cancer
Researchers at the University of Southern California have developed a
new prostate cancer vaccine that's been shown to prevent the disease in
90 percent of mice that were genetically modified to contract it.
Which is really great news if you're a mouse who's been genetically
modified to contract prostate cancer.
But scientists plan to eventually use this on men with elevated PSA
levels. Their hope is that the new vaccine will be as effective in
humans as it is in mice.
Which would also be great news, except the PSA is as accurate for
predicting cancer as the Weather Channel is for predicting winning
lottery numbers.
You see, PSA stands for prostate specific antigen. It's a chemical
marker found in the blood and for decades the mainstream has been using
it as the gold standard for predicting and detecting prostate cancer.
A PSA reading over 4.0 is considered worrisome. While a reading of 10 or
more practically guarantees you a painful biopsy.
However, more recent studies have shown that, as standards of disease
prediction go, the PSA wouldn't even take the bronze, let alone the
gold. In fact, a digital rectal exam, in and of itself, could
temporarily raise one's PSA levels.
So, it's probably not too shocking to learn that two out of three men
with elevated PSAs have biopsies that turn up nothing.
There is a far more accurate way of predicting prostate cancer (as well
as other cancers), called the AMAS (anti-malignen antibody in serum)
test.
And it's been proven to be over 90 percent accurate. However, for
whatever reason, it's been slow to catch on in mainstream medicine.
That's not to completely undermine the value of this discovery. As it
happens, only two out of 20 genetically modified mice that received the
vaccine developed cancer at the end of a year. While every mouse in the
control group had died.
Pretty impressive really.
However, the fact that genetically modified mice do not always respond
comparably to humans, aside. There is one other drawback to this
discovery.
The two-stage vaccination actually uses a DNA fragment coded to alert
immune cells to attack a protein found in prostate cancer cells. So
there is a concern that the DNA fragment could mutate and make the
immune system attack healthy cells as well.
In essence, replacing prostate cancer with an auto-immune disorder.
And, although this kind of response was not seen in the mouse
experiment, it's still a very real concern. Especially once it's
translated into a human study where, I can only hope, they won't be
genetically modifying men to contract prostate cancer first...
...but stranger things have happened. I'll be sure to keep you posted.
Yours in good health,
Allan Spreen, M.D.
Chief Research Advisor
NorthStar Nutritionals [An affiliate of HSI-Baltimore]
It's Good to Know
When it comes to prostate cancer, the "old" tactic of watchful waiting
may actually be the way to go.
In a recent study of approximately 9,000 men -- half of which were over
75 -- who chose to delay treatment, or skip it altogether, only 10
percent had died from the disease a decade later.
Since prostate cancer tends to progress very slowly, often times the
outcomes of its treatment (impotence and incontinence are the biggies)
are far worse than symptoms of the disease itself.
Study leader, Grace Lu-Yao, of Robert Wood Johnson Medical School in New
Jersey noted that, since treatments tend to be toughest on older men,
those with early-stage cancers are the best candidates for skipping or
delaying treatment.
However, she said, "If people are younger or have more advanced disease,
I wouldn't say this is a safe option."
Of course, in conclusion, my suggestion would be work with your doctor
to decide what's best for you. But don't be afraid to get a second or
even a third opinion if you feel his approach is more aggressive than
you're comfortable with.
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/cancercured/
<*> Your email settings:
Individual Email | Traditional
<*> To change settings online go to:
http://groups.yahoo.com/group/cancercured/join
(Yahoo! ID required)
<*> To change settings via email:
mailto:cancercured-digest@yahoogroups.com
mailto:cancercured-fullfeatured@yahoogroups.com
<*> To unsubscribe from this group, send an email to:
cancercured-unsubscribe@yahoogroups.com
<*> Your use of Yahoo! Groups is subject to:
Tidak ada komentar:
Posting Komentar